Canada Research Chair (Tier 1 or 2) in Tuberculosis
University of Saskatchewan
The incumbent would be an expert in TB research and would have the opportunity to work with underserved communities in collaboration with clinician investigators, microbiologists, immunologists, other basic scientists, and public health officials, to provide novel approaches to mitigate the public health challenges of TB inextricably linked to issues of poverty, overall health status, and inequitable access to healthcare resources. As many of these problems are similar around the world, such mitigation strategies could have significant international impact. In an exceptional circumstance, a Tier 2 Canada Research Chair may be selected. Canada Research Chairs (CRC) are part of the national strategy to make Canada one of the world's top countries in research and development (http://www.chairs-chaires.gc.ca).
Infectious disease remains one of the most urgent and complex threats to the health of communities across Canada and around the globe. In Saskatchewan, the TB incidence in 2016 was nearly twice the national average with an even higher incidence among Saskatchewan First Nations people. Saskatchewan also has the highest provincial HIV incidence rate in Canada. In addition to this background, the proposed theme area builds on areas of strength at this University, including Indigenous Health, One Health and Synchrotron Science. The University of Saskatchewan has the broadest diversity of colleges relevant to infectious disease in Canada including medicine, veterinary medicine, agriculture and VIDO-InterVac. Across campus, there are over 130 researchers in more than 20 disciplines contributing to infectious disease research. Funded in part by CFI, University of Saskatchewan recently invested over $600-million in world-class research space and facilities, including the new $145-million containment level 3 laboratory facilities for small and large animal work, new beam lines at Canada’s only synchrotron, a multidisciplinary Health Sciences complex, and a full-service Clinical Trial Support Unit in partnership with the Saskatchewan Health Authority.
Saskatchewan has a distinguished human TB Prevention and Control Program, and the successful candidate will have access to the longest-running bank of TB cultures with matched epidemiological data in North America. The Mycobacterial Pathogenesis and Tuberculosis Research Program at VIDO-InterVac uses an integrated approach to generate knowledge with the goal of developing novel TB vaccines and treatments. This group would provide a strong research collaboration for the CRC, with the intent of strengthening College of Medicine and VIDO linkages.
The CRC will have the opportunity to work with an already engaged network of partners including the Federation of Sovereign Indigenous Nations (FSIN), Northern Inter-Tribal Health Authority (NITHA), Saskatoon Tribal Council (STC), the Northern Saskatchewan Population Health Unit, the Saskatchewan Health Authority, the Canadian Immunization Research Network (CIRN), the Canadian Vaccine Evaluation Centre, as well as corporate partners, including the Athabasca Basin Development, Cameco, Orano and members of Canada’s vaccine sector (e.g. Sanofi, GSK, Medicago).
The University of Saskatchewan is one of Canada’s top 15 research-intensive universities. Its main campus is situated on Treaty 6 Territory and the Homeland of the Métis. The University of Saskatchewan is located in Saskatoon, Saskatchewan, with a diverse and thriving economic base, a vibrant arts community and a full range of leisure opportunities. The University has a reputation for excellence in teaching, research and scholarly activities and offers a full range of undergraduate, graduate, and professional programs to a student population of over 25,000.
Candidates should exemplify excellence, creativity, and leadership in research through an internationally recognized program.
The successful candidate will possess either a PhD, MD, or MD/PhD degrees in an area related to the focus of the CRC call. Candidates must possess the necessary qualifications to be appointed at the Full Professor rank or the Associate Professor rank with the intent of being promoted to Full Professor within two years for a Tier 1 position or as an Assistant Professor or Associate Professor for a Tier 2 position.
Candidates must also have an established research program with a focus on tuberculosis. This includes demonstrated research impact through quality publications in peer-reviewed venues or equivalent, in a field relevant to the focus of the Chair. It will also include demonstrated capability as an instructor in formal or informal settings including the training of highly qualified personnel. Inter-disciplinary work will be critical to the success of the chair and demonstrated leadership in inter-disciplinary teams is expected. The successful candidate will also be expected to attract external research funding.
This call is for a Tier 1 Canada Research Chair position. In exceptional circumstances, a candidate may be selected, instead, for a Tier 2 Canada Research Chair. For a Tier 1 Chair, the successful applicant will be appointed as a Full or Associate Professor. Tier 1 chairs are outstanding and innovative world-class researchers whose accomplishments have had a major impact in their field and are recognized internationally as leaders in their field.For a Tier 2 Chair, the successful applicant will be appointed as an Associate or Assistant Professor. Tier 2 Chairs are intended for exceptional emerging scholars (i.e., candidates must have less than 10 years of experience as an active researcher in their field at the time of nomination). Applicants who are more than 10 years from having earned their highest degree (and where career breaks exist, such as maternity, parental or extended sick leave, clinical training, etc.) may have their eligibility for a Tier 2 Chair assessed through the program’s Tier 2 justification process. Please consult the CRC website for eligibility details or contact the Strategic Research Initiatives (SRI) unit for more information (firstname.lastname@example.org).
Interested candidates must visit the posting at the following link to view instructions on how to apply: